Clinical research in diabetes, endocrinology and metabolism, with structured PICO summaries and commentary for healthcare professionals.
Browse the trial library · Landmark trial guides · PICO summaries
Latest articles
- EMPACT-MI: Empagliflozin After MI Missed Its Primary Endpoint
- DAPA-MI: Dapagliflozin After MI Improved Cardiometabolic Outcomes Only
- EMPULSE: In-Hospital Empagliflozin Helped in Acute Heart Failure
- SOLOIST-WHF: Sotagliflozin Near Discharge Cut Heart Failure Events
- SCORED: Sotagliflozin Cut Heart Failure Events in Diabetes With CKD
- VERTIS CV: Ertugliflozin Non-Inferior but Not Superior for MACE
- DELIVER: Dapagliflozin Cut Worsening Heart Failure in HFmrEF and HFpEF
- EMPEROR-Preserved: Empagliflozin Cut Heart Failure Events in HFpEF
Browse by clinical area
For healthcare professionals. Educational use only; not a substitute for clinical judgement. Editorial guidelines.

